Your activity: 2 p.v.

Society guideline links: Inborn errors of immunity (previously called primary immunodeficiencies)

Society guideline links: Inborn errors of immunity (previously called primary immunodeficiencies)

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

International Union of Immunological Societies (IUIS) Expert Committee: Human inborn errors of immunity – Update on the classification (2022)

IUIS: 2017 phenotypic classification for primary immunodeficiencies (published 2018)

Canada

Canadian Paediatric Society (CPS): Practice point on safe living strategies for the immunocompromised child (2019)

CPS: Practice point on immunization of the immunocompromised child – Key principles (2018)

Canadian Blood Services (CBS) and National Advisory Committee on Blood and Blood Products (NAC): The use of immunoglobulin therapy for patients with primary immune deficiency – An evidence-based practice guideline (2010)

United States

American Academy of Allergy, Asthma, and Immunology (AAAAI): Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases – A working group report (2020)

AAAAI: Update on the use of immunoglobulin in human disease – A review of evidence (2017)

AAAAI/American College of Allergy, Asthma, and Immunology (ACAAI), and Joint Council of Allergy, Asthma, and Immunology (JCAAI): Practice parameter for the diagnosis and management of primary immunodeficiency (2015)

Immune Deficiency Foundation (IDF): Diagnostic and clinical care guidelines for primary immunodeficiency, 3rd edition (2015)

Choosing Wisely: Don't recommend replacement immunoglobulin therapy for recurrent infections unless impaired antibody responses to vaccines are demonstrated (2012)

Europe

European Group for Blood and Marrow Transplantation (EBMT)/European Society for Immunodeficiencies (ESID): Guidelines for haematopoietic stem cell transplantation for primary immunodeficiencies (2017)

United Kingdom

British Society for Immunology (BSI)/United Kingdom Primary Immunodeficiency Network (UKPIN): Consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders (2019)

Australia-New Zealand

Australasian Society of Clinical Immunology and Allergy (ASCIA): Position statement – Subcutaneous immunoglobulin (SCIg) (2018)

ASCIA: Primary immunodeficiencies (PID) – Clinical update (2017)

Topic 112831 Version 9.0